Dolute­gravir CAS 1051375-16-6

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions & Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

1051375-16-6

Name

Dolute­gravir

Syn­onyms

(4R,12aS)-N-(2,4-Difluorbenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazin-9-carboxamid [Ger­man] [ACD/IUPAC Name] (4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide [ACD/IUPAC Name] (4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-méthyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide [French] [ACD/IUPAC Name] (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide 1051375-16-6 [RN] 2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)- [ACD/​Index Name] 9261 DKO1W9H7M1 Dolute­gravir [INN] [USAN] [Wiki] Dolute­gravir [Span­ish] [INN] Doluté­gravir [French] [INN] Dolute­gravirum [Latin] [INN] GSK 1349572 S-349572 (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0³,â¸]tetradeca-10,13-diene-13-carboxamide (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-a]pyrido[1,2-d]pyrazine-9-carboxamide (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1 ,3]oxazine-9-carboxamide (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide [1051375-16-6] 1051375-19-9 [RN] DLU Dolute­gravir (GSK1349572) Dolutegravir(S/GSK1349572) dolute­gravir/​GSK1349572/S-349572 GSK 1349572|GSK-1349572|GSK1349572|S-349572|Tivicay® GSK1349572 GSK-1349572 MFCD20488027 S/GSK 1349572 S/GSK1349572 S/GSK1349572 (GSK1349572) S/GSK1349572 ;GSK1349572;S/GSK 1349572 ;GSK-1349572 ;GSK 1349572 Tivicay [Trade name] Tivicay® UNII :DKO1W9H7M1 UNII-DKO1W9H7M1

Mol­e­c­u­lar Structure

SMILES

C[C@@H]1CCO[C@@H]2N1C(=O)c3c(c(=O)c(cn3C2)C(=O)NCc4ccc(cc4F)F)O

Std­InChI

InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1

Std­InChIKey

RHWKPHLQXYS­BKR-BMIGLB­­TASA-N

Mol­e­c­u­lar Formula

C20H19F2N3O5

Mol­e­c­u­lar Weight

419.3787664

Safe­ty Data

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Dolute­gravir CAS 1051375-16-6

Stan­dard

Enter­prise stan­dard

Puri­ty

99%min

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the new drug of Anti-AIDS.

Links

This prod­uct is devel­oped by our R&D com­pa­ny Wat­son­noke Sci­en­tif­ic Ltd(http://​www​.wat​son​noke​.com/), and here is the cor­re­spond­ing linkhttp://​www​.wat​son​noke​.com/​d​o​l​u​t​e​g​r​a​v​i​r​-​c​a​s​-​1​0​5​1​3​7​5​-​1​6​-6/”

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).